Y70 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint Y70 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Aurobindo Pharma Limited.

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Y70

Rabeprazole Sodium Delayed-Release

Imprint: Y70
Strength: 20 mg
Color: Yellow
Size: 8.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Proton pump inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: Aurobindo Pharma Limited
National Drug Code (NDC): 65862-0721
Inactive Ingredients: diacetylated monoglycerides, ethylcellulose (7 mPa.s), ferric oxide yellow, hypromellose phthalate (31% phthalate, 40 cst), magnesium stearate, mannitol, magnesium oxide, magnesium hydroxide, sodium carbonate, magnesium silicate, titanium dioxide, ferrosoferric oxide, shellac
Note: Inactive ingredients may vary.